121 related articles for article (PubMed ID: 9490555)
21. Lipid metabolism and APC: implications for colorectal cancer prevention.
Watson AJ; Dubois RN
Lancet; 1997 Feb; 349(9050):444-5. PubMed ID: 9040567
[No Abstract] [Full Text] [Related]
22. COX-2 and colon cancer.
Taketo MM
Inflamm Res; 1998 Oct; 47 Suppl 2():S112-6. PubMed ID: 9831333
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention comes to clinical practice: COX-2 inhibition in familial adenomatous polyposis.
Bresalier RS
Gastroenterology; 2000 Dec; 119(6):1797-8. PubMed ID: 11113106
[No Abstract] [Full Text] [Related]
25. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients.
Chen LC; Hao CY; Chiu YS; Wong P; Melnick JS; Brotman M; Moretto J; Mendes F; Smith AP; Bennington JL; Moore D; Lee NM
Cancer Res; 2004 May; 64(10):3694-700. PubMed ID: 15150130
[TBL] [Abstract][Full Text] [Related]
26. Cancer research. Anti-inflammatories inhibit cancer growth--but how?
Marx J
Science; 2001 Jan; 291(5504):581-2. PubMed ID: 11233414
[No Abstract] [Full Text] [Related]
27. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.
Higuchi T; Iwama T; Yoshinaga K; Toyooka M; Taketo MM; Sugihara K
Clin Cancer Res; 2003 Oct; 9(13):4756-60. PubMed ID: 14581346
[TBL] [Abstract][Full Text] [Related]
29. Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis.
Yang K; Edelmann W; Fan K; Lau K; Leung D; Newmark H; Kucherlapati R; Lipkin M
Cancer Res; 1998 Dec; 58(24):5713-7. PubMed ID: 9865728
[TBL] [Abstract][Full Text] [Related]
30. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
[TBL] [Abstract][Full Text] [Related]
31. [From gene to disease; the APC gene and familial adenomatous polyposis coli].
van der Luijt RB; Tops CM; Vasen HF
Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2007-9. PubMed ID: 11072519
[TBL] [Abstract][Full Text] [Related]
32. Modulation of cyclooxygenase-2 expression by APC in HT-29 human colorectal carcinoma cells.
Hsi LC; Angerman-Stewart J; Eling TE
Adv Exp Med Biol; 2002; 507():127-31. PubMed ID: 12664576
[No Abstract] [Full Text] [Related]
33. Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam.
Dobbie Z; Muller PY; Heinimann K; Albrecht C; D'Orazio D; Bendik I; Müller H; Bauerfeind P
Anticancer Res; 2002; 22(4):2215-20. PubMed ID: 12174906
[TBL] [Abstract][Full Text] [Related]
34. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW
Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127
[TBL] [Abstract][Full Text] [Related]
35. The role of sulindac in familial adenomatous polyposis patients with ileal pouch polyposis.
Ho JW; Yuen ST; Chung LP; So HC; Kwan KY
Aust N Z J Surg; 1999 Oct; 69(10):756-8. PubMed ID: 10527361
[No Abstract] [Full Text] [Related]
36. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM
Cancer Res; 2002 Jan; 62(2):506-11. PubMed ID: 11809702
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase 2: from inflammation to carcinogenesis.
Ristimäki A
Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
Hansen-Petrik MB; McEntee MF; Jull B; Shi H; Zemel MB; Whelan J
Cancer Res; 2002 Jan; 62(2):403-8. PubMed ID: 11809688
[TBL] [Abstract][Full Text] [Related]
39. Connexin43 is overexpressed in Apc(Min/+)-mice adenomas and colocalises with COX-2 in myofibroblasts.
Husøy T; Knutsen HK; Cruciani V; Olstørn HB; Mikalsen SO; Løberg EM; Alexander J
Int J Cancer; 2005 Sep; 116(3):351-8. PubMed ID: 15800939
[TBL] [Abstract][Full Text] [Related]
40. [Mouse model for familial adenomatous polyposis coli and APC gene].
Ito M; Miura S; Noda T
Tanpakushitsu Kakusan Koso; 1995 Oct; 40(14):2035-44. PubMed ID: 8532859
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
